These findings also bring to light the importance of thePI3K/Akt pathway suggesting it as an essential target within CSC andchemoresistant phenotypes in ovarian cancer, though additional work should bedone to validate these findings in additional cell lines. This evidence concerns the gene AKT1 and ovarian carcinoma.